However, at 1 week, ultrasound showed a trend towards a lower ratio of circuit flow to CCO (0.346 ± 0.09; P = 0.09), higher UA‐PI (0.67 ± 0.18; P = 0.03) and a higher DV‐PI (0.73 ± 0.29; P = 0.07) in the three non‐survivors compared to survivors.
Nevertheless, patients that received a total absolute number of MNCs above the median (64x108 cells) showed a trend towards a higher response rate (75% vs 61%, p=0.09).
However, low serum AMH women had significantly greater live birth rates ( p < 0.05) and showed a trend towards greater clinical pregnancy rates compared to women in the average and high AMH groups ( p = 0.09).
In addition, DM + HC + CKD showed a trend towards an increase in liver fat deposition ( p = 0.09), which correlated positively with plasma levels of total cholesterol ( r 2 = 0.519, p < 0.05) and correlated inversely with ASAT ( r 2 = 0.466, p < 0.05).
Older adults ( M = 0.32, SE = 0.03) showed a trend of lower performance than younger adults, p = 0.09, whereas children and older adults did not differ reliably, p > 0.05.
Additionally, vaptans did not affect the incidence of variceal bleeding (RR: 0.96, p = 0.86), showed a trend of reduced incidence of hepatic encephalopathy (RR: 0.86, p = 0.09), significantly reduced the incidence of spontaneous bacterial peritonitis (RR: 0.75, p = 0.03), but did not significantly affect the risk of hepatorenal syndrome or renal failure (RR: 1.09, p = 0.36).
In addition to assessing statin-induced improvements in AA outcome after surgery, Randall et al [ 10 ] analyzed the impact of statins and antiplatelet therapy in patients who received AAA repair, elective carotid endarterectomy, carotid stenting, and suprainguinal and infrainguinal bypass from 2005 to 2012 in New England and found that patients who used antiplatelet and statin therapy preoperatively showed a trend towards lower 30-day mortality (odds ratio, 0.75; 95% CI, 0.5–1.05; P = .09).
Patients showed a trend towards a greater rate of anti-saccade errors ( p = 0.09) compared to controls.
Expression of phosphorylated inositol-requiring enzyme 1 (P-IRE1), a marker of endoplasmic reticulum stress, was significantly greater in the CLO group than the TIC group (P = 0.038); it also showed a trend toward greater expression in the CLO group than in the CTL group (P = 0.090), although there was no significant difference between the CTL and TIC groups (N = 7 for CLO; N = 6 for TIC and CTL, Fig 3F ).
There was no difference in the mean convenience score between the two cohorts (mean±SD 82.2±16.1 for the Maltese version vs 84.0±13.7 for the English version, p =0.28), while patients who completed the Maltese version showed a trend toward lower satisfaction score (65.2±11.5 vs 67.6±14.6, respectively, p =0.09), corresponding to lower anticoagulant treatment satisfaction.
Inadvertent EBI after field intubation showed a trend towards a higher proportion of early VAP (30% vs. 17%: p = 0.09), and of both early VAP and early VAT (39% vs. 23%: p = 0.065) ( Table 2 ).
Compared to the standard stent, the anti-reflux stent showed a trend towards reduction in the dysphagia score without reaching a statistical significance [Standardized mean difference (SMD): -0.33 (-0.71, 0.05); P = 0.09, I 2 : 37%].
Comparison between pioglitazone dosage showed that 30 mg fixed-dose was similarly efficacious as the comparators (WMD: −0.01, 95% CI: −0.29 to 0.28, p = 0.96), whereas 45 mg fixed-dose showed a trend towards greater HbA1c reduction compared with other AD drugs (WMD: −0.48, 95% CI: −1.04 to 0.07, p = 0.09).
The cohort receiving belinostat showed a trend of improved 6-month PFS compared to the control cohort ( P = .09); however, this difference was mitigated by 12 months ( P = .45).
Weight showed a trend (OR = 2.8; p = 0.09; 95% CI 0.99-1.04).
Given that the primary analysis showed a trend toward improved sleep quality, assessed by the mean difference in PSQI scores, with cannabis oil compared to placebo ( p = 0.09), we performed post hoc exploratory analyses to further investigate this finding.
In women, both SMI (sHR 0.94, P = 0.048) and PMI (sHR 0.58, P = 0.002) were predictors of mortality, while in men, SMI was significant (sHR 0.95, P = 0.001) and PMI showed a trend to be (sHR 0.85, P = 0.09) associated with mortality.
4a and b , OLT1177-treated mice showed a trend toward reduced total circulating leukocytes ( p = 0.09) and a significant reduction in monocytes (− 45%; p < 0.01) and granulocytes (− 38%; p < 0.05).
At comparable procedure durations (MDCT: 217±74 min, EVM: 194±57 min, p=0.15) the MDCT group showed a trend towards shorter mapping times (MDCT: 42±18 min, EVM: 49±13 min, p=0.09), particularly in cases with non-ischemic cardiomyopathy (NICM) (MDCT: 41±20 min, EVM: 54±15 min, p=0.07).
When calculated as a categorized variable, it appears that acute coronary syndrome (ACS) patients with higher TyG index levels may have a higher incidence rate of MACE [hazard ratio (HR): 2.09, 95% CI 1.68–2.62, I 2 = 87%, P < 0.00001], whereas chronic coronary syndrome (CCS) or stable CAD patients with higher TyG index levels showed a trend towards an increased incidence rate of MACE (HR: 1.24, 95% CI 0.96–1.60, I 2 = 85%, P = 0.09).
At BL, GFAP showed a trend for a correlation with haematoma volume (ρ=0.58, p=0.09).
The “C-T” haplotype formed by M2-M3 also showed a trend for association (χ 2 = 2.80, P = 0.09).
Additionally, miR‐499 was significantly upregulated by >2‐fold 6, 12, and 24 hours post‐AC compared with controls in whom it was unchanged and showed a trend toward differential regulation between treatment groups at 24 hours ( P =0.09; Figure 2 ; Table S3 ).
268 controls) were significantly higher, whereas HDL cholesterol showed a trend towards lower levels (MD −0.55 mg/dl; 95% CI −1.18, 0.08; P = 0.09) (378 cases vs . 368 controls) in men with early-onset AGA compared to controls (Fig. 3 ).
However, total fat mass [%] and total trunk fat [%], which has been validated against magnetic resonance imaging for the prediction of abdominal fat percentage (Browning et al., 2010 ), showed a trend toward a positive association with overall changes in systolic BP ( r = +0.32, p = 0.09).